AARDEX Group

AARDEX leading position in the B2B medication adherence market

blog-image
AARDEX still confirms its leading position in the B2B medication adherence market

AARDEX still confirms its leading position in the B2B medication adherence market, closing steadily more new deals with Pharma Companies, Biotech’s, Excellence Centers and Universities, over 30 countries in 2018.

Share This Post

You may also like...

Adherence - Guide for Sponsors and CROs
Breaking News

Electronic monitoring in clinical trials: a guide for sponsors and CROs

Clinical trials rely on accurate data. But what if one of the most important variables whether a patient actually takes the medication is based on guesswork? Traditional methods like pill counts, diaries, or verbal confirmation have long been the standard,